Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer CellsQingbin Cui, Zhe‐Sheng Chen, Hailing Gao et al.|Frontiers in Oncology|2019Cited by 42